Avanos Medical (AVNS) FCF Margin (2013 - 2026)
Avanos Medical recorded quarterly FCF Margin of 9.11% in Q1 2026, down 132.13% quarter-over-quarter from 28.36% in Q4 2025, and down 2045.0% year-over-year from 0.47% in Q1 2025.
Avanos Medical's FCF Margin history runs 14 years deep, the most recent figure standing at 9.11% for Q1 2026.
- In Q1 2026, FCF Margin fell 2045.0% year-over-year to 9.11%; the TTM figure through Mar 2026 stood at 5.24% (down 1307.0% YoY), while the FY2025 annual figure was 10.42%, down 340.0% from the prior year.
- FCF Margin came in at 9.11% for Q1 2026 at Avanos Medical, down from 28.36% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 36.36% in Q4 2024 to a low of 9.11% in Q1 2026.
- A 5-year average of 8.42% and a median of 11.34% in 2025 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin sank 15108 bps in 2022 and soared 3243 bps in 2024, its largest moves.
- Avanos Medical's FCF Margin stood at 24.34% in 2022, then tumbled by 84 bps to 3.92% in 2023, then soared by 827 bps to 36.36% in 2024, then declined by 22 bps to 28.36% in 2025, then tumbled by 132 bps to 9.11% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 9.11%, 28.36%, and 3.94% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | -9.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.11% |
| Dec 31, 2025 | 28.36% |
| Sep 30, 2025 | 3.94% |
| Jun 30, 2025 | -2.40% |
| Mar 31, 2025 | 11.34% |
| Dec 31, 2024 | 36.36% |
| Sep 30, 2024 | 11.74% |
| Jun 30, 2024 | 12.75% |
| Mar 31, 2024 | -7.28% |
| Dec 31, 2023 | 3.92% |
| Sep 30, 2023 | 14.71% |
| Jun 30, 2023 | -3.90% |
| Mar 31, 2023 | -6.78% |
| Dec 31, 2022 | 24.34% |
| Sep 30, 2022 | 13.41% |
| Jun 30, 2022 | 13.40% |
| Mar 31, 2022 | -1.62% |
| Dec 31, 2021 | 175.42% |
| Sep 30, 2021 | 9.99% |
| Jun 30, 2021 | 5.10% |
| Mar 31, 2021 | -4.98% |
| Dec 31, 2020 | 6.92% |
| Sep 30, 2020 | -1.02% |
| Jun 30, 2020 | -3.54% |
| Mar 31, 2020 | -6.10% |
| Dec 31, 2019 | -5.80% |
| Sep 30, 2019 | -13.83% |
| Jun 30, 2019 | -31.82% |
| Mar 31, 2019 | -21.68% |
| Dec 31, 2018 | -14.77% |
| Sep 30, 2018 | -47.55% |
| Jun 30, 2018 | -67.00% |
| Mar 31, 2018 | 10.68% |
| Dec 31, 2017 | 54.24% |
| Sep 30, 2017 | 6.25% |
| Jun 30, 2017 | 8.92% |
| Mar 31, 2017 | 18.39% |
| Dec 31, 2016 | -9.87% |
| Sep 30, 2016 | 10.64% |
| Jun 30, 2016 | 11.35% |
| Mar 31, 2016 | 8.97% |
| Dec 31, 2015 | -12.32% |
| Sep 30, 2015 | -0.08% |
| Jun 30, 2015 | -0.39% |
| Mar 31, 2015 | 3.04% |
| Dec 31, 2014 | 18.09% |
| Sep 30, 2014 | -2.15% |
| Jun 30, 2014 | 9.09% |
| Mar 31, 2014 | 4.41% |
| Dec 31, 2013 | 26.57% |